1. Home
  2. PTCT vs GVA Comparison

PTCT vs GVA Comparison

Compare PTCT & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • GVA
  • Stock Information
  • Founded
  • PTCT 1998
  • GVA 1922
  • Country
  • PTCT United States
  • GVA United States
  • Employees
  • PTCT N/A
  • GVA N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • GVA Military/Government/Technical
  • Sector
  • PTCT Health Care
  • GVA Industrials
  • Exchange
  • PTCT Nasdaq
  • GVA Nasdaq
  • Market Cap
  • PTCT 3.9B
  • GVA 4.1B
  • IPO Year
  • PTCT 2013
  • GVA 1990
  • Fundamental
  • Price
  • PTCT $52.13
  • GVA $92.29
  • Analyst Decision
  • PTCT Buy
  • GVA Strong Sell
  • Analyst Count
  • PTCT 14
  • GVA 1
  • Target Price
  • PTCT $67.64
  • GVA $76.00
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • GVA 457.3K
  • Earning Date
  • PTCT 08-07-2025
  • GVA 08-07-2025
  • Dividend Yield
  • PTCT N/A
  • GVA 0.56%
  • EPS Growth
  • PTCT N/A
  • GVA 218.05
  • EPS
  • PTCT 7.51
  • GVA 2.58
  • Revenue
  • PTCT $1,772,758,000.00
  • GVA $4,034,846,000.00
  • Revenue This Year
  • PTCT $120.38
  • GVA $7.95
  • Revenue Next Year
  • PTCT N/A
  • GVA $6.03
  • P/E Ratio
  • PTCT $6.94
  • GVA $35.80
  • Revenue Growth
  • PTCT 91.12
  • GVA 11.42
  • 52 Week Low
  • PTCT $29.02
  • GVA $65.13
  • 52 Week High
  • PTCT $58.38
  • GVA $105.20
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 62.66
  • GVA 45.43
  • Support Level
  • PTCT $44.15
  • GVA $93.50
  • Resistance Level
  • PTCT $52.70
  • GVA $96.05
  • Average True Range (ATR)
  • PTCT 1.87
  • GVA 2.16
  • MACD
  • PTCT 0.59
  • GVA -0.33
  • Stochastic Oscillator
  • PTCT 93.33
  • GVA 30.39

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

Share on Social Networks: